Tildrakizumab-Asm Suppliers & Bulk Manufacturers
Available Forms: injection (prefilled syringe)
Available Strengths: 100 mg/mL
Reference Brands: Ilumya (USA), Ilumetri (EUUK)
Category: Derma Drugs
Tildrakizumab-asmn is a humanized IgG1/k monoclonal antibody that selectively targets the p19 subunit of interleukin-23 (IL-23). By blocking IL-23 signaling, it reduces inflammation and helps clear plaques in moderate to severe plaque psoriasis. It is prescribed for adults who need systemic therapy or phototherapy. The dosing schedule includes injections at week 0, week 4, and every 12 weeks thereafter. It is administered as a subcutaneous injection under medical supervision. Tildrakizumab-asm is available in injection (prefilled syringe) and strengths such as 100 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Tildrakizumab-asm is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Tildrakizumab-asm can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Tildrakizumab-asm is used to treat adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy. It helps reduce inflammation, skin plaques, redness, and thickness by targeting specific immune pathways involved in psoriasis.
Tildrakizumab-asm is made from the active ingredient tildrakizumab-asm, a humanized monoclonal antibody that selectively blocks interleukin-23 (IL-23), along with standard excipients used in biologic injectable formulations.
The trade name for tildrakizumab-asm is Ilumya (in the USA) and Ilumetri (in the EU and other regions).
Tildrakizumab-asm is manufactured and marketed by Sun Pharma in the USA, EU, UK, and other approved global markets.
The generic name is tildrakizumab-asm.
The brand names are Ilumya and Ilumetri, depending on the country.
It is manufactured in approved biologics manufacturing facilities in the USA and Europe, as well as other globally regulated regions authorized for monoclonal antibody production.
Related Products
Ammonium Lactate
Strength:
5% to 12%
Form: Lotion / Cream
Reference Brands: AmLactin(USA)
View Details
Acitretin
Strength:
10 mg, 17.5 mg, 22.5 mg, 25 mg
Form: Capsules
Reference Brands: Soriatane (USA), Neotigason (EU)
View Details
Quick Response Guaranteed | Verified Suppliers
